The impact of HIV-1 on the malaria parasite biomass in adults in sub-Saharan Africa contributes to the emergence of antimalarial drug resistance
暂无分享,去创建一个
Umberto D'Alessandro | Robert Colebunders | U. d’Alessandro | J. Menten | R. Colebunders | Joris Menten | E. Korenromp | J. Van Geertruyden | Jean-Pierre Van geertruyden | Eline Korenromp
[1] G. Killeen,et al. Short report: entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa. , 1999, The American journal of tropical medicine and hygiene.
[2] P. Piot,et al. Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire. , 1990, The Journal of infection.
[3] R. Snow,et al. Why do some African children develop severe malaria? , 1991, Parasitology today.
[4] S. Siziya,et al. Relation between falciparum malaria and HIV seropositivity in Ndola, Zambia. , 1988, BMJ.
[5] Nicholas J White,et al. Antimalarial drug resistance. , 2004, The Journal of clinical investigation.
[6] A. Saah,et al. Childhood malaria parasitaemia and human immunodeficiency virus infection in Malawi. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[7] Robert W. Snow,et al. The public health burden of Plasmodium falciparum malaria in Africa: deriving the numbers , 2003 .
[8] O. Müller,et al. The clinical and parasitological presentation of Plasmodium falciparum malaria in Uganda is unaffected by HIV-1 infection. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[9] U. d’Alessandro,et al. CD4 T-Cell Count and HIV-1 Infection in Adults With Uncomplicated Malaria , 2006, Journal of acquired immune deficiency syndromes.
[10] A. Greenberg,et al. Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children. , 1991, The New England journal of medicine.
[11] K. Kain,et al. HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya. , 2006, The Journal of infectious diseases.
[12] U. d’Alessandro,et al. Modelling a predictable disaster: the rise and spread of drug-resistantmalaria. , 2000, Parasitology today.
[13] J. Breman,et al. Trends and risk factors for HIV-1 seropositivity among outpatient children, Kinshasa, Zaire. , 1990, AIDS (London).
[14] R. Snow,et al. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. , 1999, Bulletin of the World Health Organization.
[15] K. Marsh. Malaria disaster in Africa , 1998, The Lancet.
[16] D. Bagenda,et al. Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children. , 1997, The Pediatric infectious disease journal.
[17] D. Wolday,et al. Delayed clearance of Plasmodium falciparum in patients with human immunodeficiency virus co-infection treated with artemisinin. , 2002, Ethiopian medical journal.
[18] Averill M. Law,et al. Simulation Modeling and Analysis , 1982 .
[19] N. French,et al. HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa , 2004, AIDS.
[20] U. d’Alessandro,et al. History, Dynamics, and Public Health Importance of Malaria Parasite Resistance , 2004, Clinical Microbiology Reviews.
[21] I. Hastings,et al. Complex dynamics and stability of resistance to antimalarial drugs , 2006, Parasitology.
[22] L. Chitsulo,et al. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. , 1996, American Journal of Tropical Medicine and Hygiene.
[23] P. Olliaro,et al. Averting a malaria disaster , 1999, The Lancet.
[24] Amanda Ross,et al. An epidemiologic model of severe morbidity and mortality caused by Plasmodium falciparum. , 2006, The American journal of tropical medicine and hygiene.
[25] C. Dye,et al. World Malaria Report, 2008. , 2008 .
[26] M. Scaglia,et al. HIV-1 and parasitic infections in rural Tanzania. , 1993, Annals of tropical medicine and parasitology.
[27] W. Stahel,et al. Log-normal Distributions across the Sciences: Keys and Clues , 2001 .
[28] Brian G. Williams,et al. Malaria Attributable to the HIV-1 Epidemic, Sub-Saharan Africa , 2005, Emerging infectious diseases.
[29] J. Kublin,et al. Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi. , 2005, The Journal of infectious diseases.
[30] J. Vulule,et al. Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria , 2006, AIDS.
[31] N. French,et al. Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence , 2003, The Pediatric infectious disease journal.
[32] N. White,et al. The de novo selection of drug–resistant malaria parasites , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[33] M. Quigley,et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study , 2000, The Lancet.
[34] A. Khasnis,et al. Human immunodeficiency virus type 1 infection in patients with severe falciparum malaria in urban India. , 2003, Journal of postgraduate medicine.
[35] N. French,et al. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults , 2001, AIDS.
[36] N. French,et al. Interactions between HIV and malaria in non-pregnant adults: evidence and implications , 2006, AIDS.
[37] J. P. Ekwaru,et al. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study , 2006, The Lancet.
[38] R. Quick,et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda , 2004, The Lancet.
[39] E. Asamoah-odei,et al. HIV prevalence and trends in sub-Saharan Africa: no decline and large subregional differences , 2004, The Lancet.
[40] P. Rosenthal,et al. Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. , 2006, The Journal of infectious diseases.
[41] S. P. Kachur,et al. Preventing Childhood Malaria in Africa by Protecting Adults from Mosquitoes with Insecticide-Treated Nets , 2007, PLoS medicine.
[42] P. Kazembe,et al. Increased prevalence of malaria in HIV‐infected pregnant women and its implications for malaria control , 1999, Tropical medicine & international health : TM & IH.
[43] U. d’Alessandro,et al. HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria. , 2006, The Journal of infectious diseases.
[44] Juno Thomas,et al. Increased prevalence of severe malaria in HIV-infected adults in South Africa. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[45] T. Taylor,et al. Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi. , 2006, The Journal of infectious diseases.
[46] J. Kublin,et al. Dual Infection with HIV and Malaria Fuels the Spread of Both Diseases in Sub-Saharan Africa , 2006, Science.
[47] R. Quick,et al. Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members , 2005, AIDS.
[48] P. Brasseur,et al. Combination therapy for malaria: the way forward? , 2002, Drugs.